1. Limited Impact of Breast Cancer and Non-breast Malignancies on Survival in Older Patients with Early-Stage Breast Cancer: Results of a Large, Single-Centre, Population-Based Study
- Author
-
Henk Struikmans, J. van der Palen, Jan J. Jobsen, and Ester J. M. Siemerink
- Subjects
Male ,Oncology ,medicine.medical_specialty ,Colorectal cancer ,UT-Hybrid-D ,Breast Neoplasms ,Mastectomy, Segmental ,Malignancy ,survival ,Breast cancer ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Stage (cooking) ,Lung cancer ,older adults ,Aged ,Neoplasm Staging ,Cause of death ,Proportional hazards model ,business.industry ,Incidence (epidemiology) ,second malignancy ,medicine.disease ,Survival Analysis ,n/a OA procedure ,Survival Rate ,population-based study ,Female ,business - Abstract
Aims To analyse the disease-free survival and overall survival in older adults with breast cancer after breast-conserving therapy, focusing on the relevance of non-breast malignancy (NBM) with respect to survival rates. Materials and methods Analyses were based on 1205 women aged 65 years and older with breast cancer treated with breast-conserving therapy between 1999 and 2015. Patients were divided into three age categories: 65–70, 71–75 and >75 years. Multivariate survival analysis was carried out using Cox regression analysis. Results The two youngest age categories showed excellent results, with a 12-year disease-free survival of 84.6 and 86.3%, respectively. We noted a 17.2% incidence of NBM, particularly for colon cancer and lung cancer. Most (72.9%) occurred after a diagnosis of breast cancer. Of those 72.9%, about 50% died as a result of NBM within 2 years of the diagnosis of NBM. The overall 12-year NBM-specific survival was 92.0%. The 12-year overall survival was 60.0% for all and for the three abovementioned age categories was 73.3, 54.4 and 28.4%, respectively. The cause of death for all was predominantly non-malignancy-related morbidity. Conclusion The impact of breast cancer on life expectancy was limited, in particularly for women aged 65–75 years. The relevance of NBM on survival was limited.
- Published
- 2022